How to Help Your Patients Find Miebo in Stock: A Provider's Guide

Prescribing Miebo is the first step. Getting your patients to actually fill and use it — that's where the workflow challenges begin. Between insurance prior authorization, pharmacy stocking variability, and cost barriers, many patients experience significant friction between the prescription pad and the prescription bottle. This guide walks through exactly what your practice can do to close that gap.

Why Your Patients Are Struggling to Fill Miebo

Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb) was approved in May 2023. Despite strong and growing formulary coverage — approximately 75% of commercial plans and 65% of Medicare Part D plans — patients frequently hit one or more of these barriers:

• Pharmacy doesn't carry it in stock (common at retail chains and some independent pharmacies)
• Insurance requires prior authorization before covering the fill
• Sticker shock on the $800+ retail price, especially for Medicare/Medicaid patients who can't use the copay card
• Confusion about how to use BlinkRx or where to send the prescription

Strategy 1: Default to E-Prescribing Miebo to BlinkRx

The single most impactful workflow change you can make is defaulting all new Miebo prescriptions to BlinkRx U.S. (Boise, Idaho). Here's why this matters for both your practice and your patients:

• BlinkRx contacts the patient by text within approximately 15 minutes of receiving the prescription
• BlinkRx determines the copay and applies available savings automatically
• BlinkRx handles prior authorization if required, reaching out to your office only if clinical documentation is needed
• BlinkRx delivers Miebo with free shipping to the patient's home
• BlinkRx services all 50 states — no gaps in geographic coverage

To set this up in your practice, add BlinkRx U.S. (Boise, ID) to your EMR's preferred pharmacy list. Most major EHR platforms already have BlinkRx available in the dropdown. For practices using paper scripts or fax, BlinkRx also accepts prescriptions by phone or fax.

Strategy 2: Proactive Prior Authorization Documentation

The best PA is one that doesn't require a phone call to your office. Build the foundation in your clinical note at the time of prescribing:

1. Document dry eye disease diagnosis with ICD-10 code (H04.12x for dry eye syndrome, H04.14x for dry eye with lacrimal gland dysfunction)
2. Specify the DED subtype: evaporative, MGD-associated, or mixed. Include meibography findings and tear film breakup time if available
3. Document prior treatments tried and outcomes: OTC artificial tears, warm compresses, prior Rx (cyclosporine, lifitegrast) — including duration and response
4. Explain why Miebo is specifically appropriate: mechanism targeting tear evaporation, unique among FDA-approved options for DED associated with MGD

Strategy 3: Have Samples Ready for New Starts

Bausch + Lomb provides Miebo samples to prescribers. Keep a supply on hand for new Miebo starts — particularly for patients who are likely to face PA review periods, insurance adjudication delays, or first-fill confusion. Samples let patients begin therapy on the day of the appointment, improving adherence and confirming tolerability before the insurance process concludes.

Strategy 4: Educate Patients on the Savings Program Before They Leave

Before a commercially insured patient leaves your office with a Miebo prescription, have your front desk or tech team walk them through the MIEBO MySavings Program copay card. Eligible commercially insured patients may pay as little as $0 per fill. Key details to communicate:

• The card is available at MIEBO.CopaySavingsProgram.com and can be printed or stored digitally
• It is NOT valid for Medicare, Medicaid, TRICARE, or other government program patients
• GoodRx and SingleCare discount cards are available for cash-pay patients (approximately $778–$810)

Strategy 5: Use medfinder to Route Prescriptions to Stocked Pharmacies

For patients who prefer in-person pickup, medfinder for Providers gives your staff real-time visibility into which pharmacies near your patient currently have Miebo in stock. Rather than sending the patient out with a prescription and hoping their pharmacy has it, you can direct the prescription to a confirmed location.

Quick Reference: Miebo Access Checklist for Prescribers

• Add BlinkRx U.S. to preferred pharmacy in EMR ✓
• Document DED subtype and prior therapy in clinical note ✓
• Have Miebo samples for new starts ✓
• Provide copay card info to commercially insured patients ✓
• Have medfinder available for pharmacy stock routing ✓

The Bottom Line

The biggest predictor of a patient successfully starting and staying on Miebo is the quality of the support they receive at the prescription moment. A robust in-office workflow — BlinkRx, samples, copay card education, and tools like medfinder for Providers — converts more prescriptions into filled prescriptions and better patient outcomes.